Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/01/2007CA2649842A1 Composition containing peptide as active ingredient
11/01/2007CA2649820A1 Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649575A1 Treatment of melanoma
11/01/2007CA2649522A1 Medicaments
11/01/2007CA2648936A1 Glp-1 compounds
11/01/2007CA2648558A1 Molecular dissection of the role of the pi3-kinase/akt pathway; redirection from pro-survival signaling to a death pathway through nuclear relocation of akt
11/01/2007CA2647099A1 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
11/01/2007CA2647087A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007CA2645832A1 Hcv vaccinations
10/2007
10/31/2007EP1849878A1 Means and methods for diagnosing and treating cancer based on the frmd3 gene
10/31/2007EP1849870A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM)
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP1849479A1 Ameliorating agent for symptoms resulting from joint diseases
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
10/31/2007EP1849475A1 Synergistic use of thiazolidinediones with glucagon-like peptide-1 and agonists thereof to treat non-insulin dependent diabetes
10/31/2007EP1849474A1 Antimicrobial peptide and use thereof
10/31/2007EP1849463A2 Microbial cellulose materials for use in transdermal drug delivery systems, methods of manufacture and use
10/31/2007EP1849434A1 Coating for stents
10/31/2007EP1848806A1 Anti-t cell and autoantigen treatment of autoimmune disease
10/31/2007EP1848804A2 Anti-muci alpha beta antibodies
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
10/31/2007EP1848738A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes
10/31/2007EP1848737A2 Homogeneous preparations of il-31
10/31/2007EP1848731A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848463A2 Method of conjugating aminothiol containing molecules to vehicles
10/31/2007EP1848456A2 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity
10/31/2007EP1848455A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis
10/31/2007EP1848454A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody
10/31/2007EP1848453A1 Treatment for neurodegeneration
10/31/2007EP1848452A2 Use of nkg2d receptor/nkg2d ligand interaction blockers in the treatment of auto-immune diseases
10/31/2007EP1848415A1 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis
10/31/2007EP1848414A2 Method for treating gefitinib resistant cancer
10/31/2007EP1848407A2 Oral pharmaceutical composition
10/31/2007EP1848270A2 Transmucosal administration of drug compositions for treating and preventing disorders in animals
10/31/2007EP1608395A4 Anticancer agent comprising lk8 protein as an active ingredient
10/31/2007EP1534737A4 Peptide antagonists of tgf-beta family members and therapeutic uses thereof
10/31/2007EP1509606B1 Allergen from mugwort pollen
10/31/2007EP1501533A4 Peptide inhibitors of protein kinase c-gamma for pain management
10/31/2007EP1455831B1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1362915B1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same
10/31/2007EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1165791B1 Human cytokine as ligand of the zalpha receptor and uses thereof
10/31/2007EP1163912B1 Gene therapeutics
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1131422B1 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
10/31/2007EP1064020A4 Methods for diagnosing and treating autoimmune disease
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP1012189B1 Treatment of obesity
10/31/2007EP1012173B1 Isolated decapeptides which bind to hla molecules, and the use thereof
10/31/2007EP1011707B1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007EP0851030B9 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO
10/31/2007DE60126947T2 Behandlung der glykogenspeicherkrankheit typ ii Treatment of glycogen storage disease type ii
10/31/2007CN101065482A Novel shuttle vector
10/31/2007CN101065401A Osteoprotegerin variant proteins
10/31/2007CN101065398A Peptides and APL-type derivatives of hsp60 and pharmaceutical compositions
10/31/2007CN101065365A Use of compositions comprising farnesyl dibenzodiazepinones for treating neoplastic cells and conditions
10/31/2007CN101065143A Treatment of neurological deficits in the striatum or substantia nigra pars compacta
10/31/2007CN101065142A Treatment of neurological deficits in the striatum or substanta nigra pars compacta
10/31/2007CN101065141A Plant pr-5 proteins as mammalian therapeutic agents
10/31/2007CN101065140A Use of histones for the early diagnosis and/or preventative therapy of virally-infected living cells and a biochip for carrying out said diagnosis
10/31/2007CN101065139A Ocular agent delivery systems
10/31/2007CN101065138A Compounds that inhibit hsp90 protein-protein interactions with iap proteins
10/31/2007CN101065137A G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
10/31/2007CN101065136A Prion protein binding materials and methods of use
10/31/2007CN101065135A Compositions and methods related to heart failure
10/31/2007CN101065134A Polymeric compositions and related methods of use
10/31/2007CN101065133A Pancreatic polypeptide family motifs and polypeptides comprising the same
10/31/2007CN101065131A Antimicrobial agents
10/31/2007CN101065116A Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
10/31/2007CN101063141A Moraxella(branhamella) catarrhalis antigens
10/31/2007CN101063130A Recombined protein having phenotypic knock-out effect on chemotropism factor receptor CXCR4
10/31/2007CN101063117A White-browed snake venom blood coagulation enzyme and its extraction method and application
10/31/2007CN101063112A Nucleoside diphosphokinase A oxidation-reduction isomer
10/31/2007CN101063103A Hainan sporic scorpion antibiotic and preparation method and application
10/31/2007CN101063102A East-Asia scorpion antibiotic peptide gene and preparation method and application
10/31/2007CN101062955A Fusion protein having inhibitory action on tumour cell and its coding gene and application
10/31/2007CN101062954A Fusion protein having blood vessel formation against function and its coding gene and application
10/31/2007CN101062953A Immune toxin and preparation method and usage
10/31/2007CN101062952A Fusion protein comprised of human serum and interferon and its coding gene and application
10/31/2007CN101062950A Polyethylene glycol modified thymus peptide 1 derivative
10/31/2007CN101062948A Monomer quick-effective insulin and preparation method and usage thereof
10/31/2007CN101062947A Ciliary neurotrophy factor polypeptide allosteric and application thereof
10/31/2007CN101062946A High-active liver regeneration reinforced factor and usage thereof
10/31/2007CN101062945A Meretrix meretrix protein having antineoplastic action, gene order and preparation method thereof
10/31/2007CN101062940A Inhibitor of stem cell proliferation and uses thereof
10/31/2007CN101062419A Polymer conjugates of interferon beta-1a and uses
10/31/2007CN101062415A Use of IL-18 inhibitors
10/31/2007CN101062408A Oral insulin compound medicine preparation and its preparing method
1 ... 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 ... 3163